Overview of the global cell analysis market

Market research analysts at Technavio have predicted that the global cell analysis market will grow steadily at a CAGR of around 7% by 2020. The increased need for accuracy and low cost will lead to the growth in demand for automated equipment in the market, which will be one of the major growth drivers for this industry. Automated cell counters normally use optical light scattering and changes in the electrical current. Continuous technological advancements employed in automated hematology instruments have enabled the enumeration and evaluation of blood cells with greater precisions. Since automated cell counters eliminate the need for reagents or dyes, the process also becomes more cost-effective. Manufacturers are also focusing on developing user-friendly cell analyzers that do not require manual calibration or maintenance. For instance, one of the prominent vendors EKF Diagnostics has already introduced the next-generation Hemo Control POC hemoglobin analyzer, which upgrades data management functionalities and can also store the results of almost 4,000 patients.

Due to the focus on reducing their manufacturing and distribution costs, several pharmaceutical and biotechnology companies have started outsourcing their drug discovery and research activities to (contract research organizations) CROs and research institutes, as these organizations use the latest technologies and high-end instruments for product development and clinical trials. This enables the source companies to focus more on the development of pricing and marketing strategies. This change in the vendor’s focus towards pricing market marketing strategies will subsequently increase the number of organizations collaborating with CROs and will be one of the major trends gaining traction in the market in the coming years.

Competitive landscape and key vendors

The market is characterized by the presence of several large, medium-sized, and small manufacturers that provide diagnostic products and appears to be highly fragmented. The growth of the vendors depends on several factors such as market conditions, government support, and industry development. Players in the market also have the need to expand their geographical presence and also revive the domestic demand to achieve sustained growth over time. Vendors usually compete on the basis of product pricing, availability, brand, and variety. The local vendors offer cell analyzers at a comparatively lower price and pose a threat to big businesses in the market. Vendor competition in the market is intense, and the market is also expected to witness a number of vendors forming strategic partnerships to retain their share of the market.

The leading vendors in the market are -

• BD
• Danaher
• EMD Millipore
• Thermo Fisher Scientific
• GE Healthcare

The other prominent vendors in the market are Abcam, AccuBioTech, Agilent Technologies, ChemoMetec, Covance, EKF Diagnostic, ERBA Mannheim, Horiba Scientific, Icon, Illumina, Logos Biosystem, Mindray, Olympus Life Science Solutions, PerkinElmer, Quintiles, SFRI, Sigma-Aldrich, Sysmex Corporation, and Worthington Biochemical.

Segmentation by product and analysis of the cell analysis market

• Consumables
• Instruments

Accounting for a total market share of almost 58%, the consumables segment dominated the cell analysis market during 2015. This is mainly attributed to the repeated purchase of reagents and other consumables by various end-users to conduct tests. Consumables such as reagents, assay kits, and microplates will gain significance in live cell analysis due to the growing preference for in-vitro diagnostics (IVD), academics, drug discovery, agri-genomics, and personalized medicine. As a result, this market segment will continue to dominate the industry throughout the predicted period.

Geographical segmentation and analysis of the cell analysis market

• Americas
• APAC
• EMEA

This market study estimates that in terms of geography, the Americas will account for more than 42% of the global cell analysis market by 2020 and will also dominate this market throughout the forecast period. The growth in research and developments in the field of regenerative medicine in Canada and the US will be one of the major factors that will bolster the growth of the cell analyzers market in this region. Additionally, the rise in funding for the National Institute of Health and the Biomedical Advanced Research and Development Authority will also fuel this market’s growth.

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global cell analysis market?
• What are the key market trends impacting the growth of the global cell analysis market?
• What are the challenges to market growth?
• Who are the key vendors in the global cell analysis market?
• What are the market opportunities and threats faced by the vendors in the global cell analysis market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global cell analysis market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

• Global DNA Sequencing Products Market 2016-2020
• Global Human Albumin Market 2016-2020
• Clinical Immunoassay Analyzer Market in the US 2016-2020